AMN HEALTHCARE SERVICES INC (AMN)
US0017441017 - Common Stock
AMN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 113 industry peers in the Health Care Providers & Services industry. AMN has an excellent profitability rating, but there are some minor concerns on its financial health. AMN has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
In the past year AMN had a positive cash flow from operations.
In the past 5 years AMN has always been profitable.
AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of AMN (1.99%) is better than 66.37% of its industry peers.
AMN's Return On Equity of 5.96% is fine compared to the rest of the industry. AMN outperforms 69.03% of its industry peers.
AMN has a better Return On Invested Capital (4.59%) than 61.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMN is significantly above the industry average of 8.10%.
The 3 year average ROIC (17.26%) for AMN is well above the current ROIC(4.59%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.99% | ||
| ROE | 5.96% | ||
| ROIC | 4.59% |
ROA(3y)11.01%
ROA(5y)8.39%
ROE(3y)32.02%
ROE(5y)24.03%
ROIC(3y)17.26%
ROIC(5y)13.59%
1.3 Margins
The Profit Margin of AMN (1.73%) is better than 66.37% of its industry peers.
In the last couple of years the Profit Margin of AMN has declined.
AMN has a better Operating Margin (4.37%) than 62.83% of its industry peers.
In the last couple of years the Operating Margin of AMN has remained more or less at the same level.
With a Gross Margin value of 31.34%, AMN perfoms like the industry average, outperforming 58.41% of the companies in the same industry.
AMN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.37% | ||
| PM (TTM) | 1.73% | ||
| GM | 31.34% |
OM growth 3Y1.49%
OM growth 5Y-1.21%
PM growth 3Y23.47%
PM growth 5Y-3.47%
GM growth 3Y-0.1%
GM growth 5Y0.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), AMN is creating value.
Compared to 1 year ago, AMN has less shares outstanding
Compared to 5 years ago, AMN has less shares outstanding
Compared to 1 year ago, AMN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.46 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AMN (2.46) is better than 61.06% of its industry peers.
The Debt to FCF ratio of AMN is 10.26, which is on the high side as it means it would take AMN, 10.26 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 10.26, AMN is doing good in the industry, outperforming 63.72% of the companies in the same industry.
AMN has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AMN (1.27) is worse than 68.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | 10.26 | ||
| Altman-Z | 2.46 |
ROIC/WACC0.74
WACC6.17%
2.3 Liquidity
AMN has a Current Ratio of 1.18. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN's Current ratio of 1.18 is on the low side compared to the rest of the industry. AMN is outperformed by 65.49% of its industry peers.
AMN has a Quick Ratio of 1.18. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.18, AMN perfoms like the industry average, outperforming 41.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.37%.
AMN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.92% yearly.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.12%.
The Revenue has been growing by 12.15% on average over the past years. This is quite good.
EPS 1Y (TTM)-58.37%
EPS 3Y33.37%
EPS 5Y19.92%
EPS Q2Q%-69.04%
Revenue 1Y (TTM)-25.12%
Revenue growth 3Y16.55%
Revenue growth 5Y12.15%
Sales Q2Q%-19.44%
3.2 Future
The Earnings Per Share is expected to decrease by -0.91% on average over the next years.
AMN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.97% yearly.
EPS Next Y-61.29%
EPS Next 2Y-42.55%
EPS Next 3Y-26.95%
EPS Next 5Y-0.91%
Revenue Next Year-22.83%
Revenue Next 2Y-14.5%
Revenue Next 3Y-8.64%
Revenue Next 5Y-1.97%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 6.59 indicates a rather cheap valuation of AMN.
Based on the Price/Earnings ratio, AMN is valued cheaply inside the industry as 99.11% of the companies are valued more expensively.
AMN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.65.
A Price/Forward Earnings ratio of 9.49 indicates a reasonable valuation of AMN.
AMN's Price/Forward Earnings ratio is rather cheap when compared to the industry. AMN is cheaper than 92.92% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.56. AMN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.59 | ||
| Fwd PE | 9.49 |
4.2 Price Multiples
91.15% of the companies in the same industry are more expensive than AMN, based on the Enterprise Value to EBITDA ratio.
AMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AMN is cheaper than 93.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.81 | ||
| EV/EBITDA | 6.6 |
4.3 Compensation for Growth
AMN has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as AMN's earnings are expected to decrease with -26.95% in the coming years.
PEG (NY)N/A
PEG (5Y)0.33
EPS Next 2Y-42.55%
EPS Next 3Y-26.95%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMN HEALTHCARE SERVICES INC
NYSE:AMN (11/21/2024, 2:57:43 PM)
25.55
+0.75 (+3.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap970.90M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.59 | ||
| Fwd PE | 9.49 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.99% | ||
| ROE | 5.96% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.37% | ||
| PM (TTM) | 1.73% | ||
| GM | 31.34% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-58.37%
EPS 3Y33.37%
EPS 5Y
EPS Q2Q%
EPS Next Y-61.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-25.12%
Revenue growth 3Y16.55%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y